Sp1047
AGA GUIDELINE Q&A: BIOMARKERS FOR MONITORING INFLAMMATION IN IBD
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology. This session will give DDW attendees the rare opportunity to hear about newly published and upcoming AGA guidelines from the authors of the guideline themselves, including a Question and Answer portion. It also provides an additional public forum to have the guidelines heard and discussed, in addition to our 30-day public comment period, contributing to an open and transparent process of guideline development.
AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology. This session will give DDW attendees the rare opportunity to hear about newly published and upcoming AGA guidelines from the authors of the guideline themselves, including a Question and Answer portion. It also provides an additional public forum to have the guidelines heard and discussed, in addition to our 30-day public comment period, contributing to an open and transparent process of guideline development.
Presenters
Massachusetts General Hospital
Tracks
Related Products
PANEL DISCUSSION
In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…
GUT MICROBIAL METABOLISM OF 5-ASA IS PROSPECTIVELY ASSOCIATED WITH TREATMENT FAILURE
The microbiome plays a central role in intestinal inflammation in IBD. It is influenced by environmental factors included diet…
ANTIBIOTIC USE AMONG PEDIATRIC PATIENTS WITH PERIANAL COMPLICATIONS OF CROHN’S DISEASE IN A MULTICENTER COHORT: THE CASE FOR ANTIBIOTIC STEWARDSHIP
BACKGROUND: Perianal fistulizing complications (PFC) of Crohn’s disease (CD) are highly morbid and difficult to treat. Despite the advent of biologic medications, antibiotics remain a mainstay of PFC treatment…
THE SULFUR MICROBIAL DIET AND RISK OF INFLAMMATORY BOWEL DISEASE
BACKGROUND The gut microbiome is central to Crohn’s disease (CD) pathogenesis but the relative contribution of different environmental factors to disease compositional variation is unknown…
